Interferon-Alpha Triggers B Cell Effector 1 (Be1) Commitment

• Marie-Ghislaine de Goër de Herve,

  Affiliations INSERM U-1012 and Université Paris-Sud, Bicêtre, France, unité d'Immunologie Biologique, hôpital de Bicêtre, Bicêtre, France

  ⨯
• Deniz Durali,

  Affiliations INSERM U-1012 and Université Paris-Sud, Bicêtre, France, TUBITAK Marmara Research Center, Genetic Engineering and Biotechnology Institute (GEBI), Vaccine Technology Laboratory, Gebze-Kocaeli, Turkey

  ⨯
• Bamory Dembele,

  Affiliation INSERM U-1012 and Université Paris-Sud, Bicêtre, France

  ⨯
• Massimo Giuliani,

  Affiliation INSERM U-542, Villejuif, France

  ⨯
• Tu-Anh Tran,

  Affiliation INSERM U-1012 and Université Paris-Sud, Bicêtre, France

  ⨯
• Bruno Azzarone,

  Affiliation INSERM U-542, Villejuif, France

  ⨯
• Pierre Eid,

  Affiliation INSERM U-542, Villejuif, France

  ⨯
• Marc Tardieu,

  Affiliation INSERM U-1012 and Université Paris-Sud, Bicêtre, France

  ⨯
• Jean-François Delfraissy,

  Affiliation INSERM U-1012 and Université Paris-Sud, Bicêtre, France

  ⨯
• Yassine Taoufik

  * E-mail: yassine.taoufik@bct.aphp.fr

  Affiliations INSERM U-1012 and Université Paris-Sud, Bicêtre, France, unité d'Immunologie Biologique, hôpital de Bicêtre, Bicêtre, France

  ⨯